The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


South Korea's Capital Markets Rebound as Foreign Investors Return
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
U.S. Stock Futures Fall as Iran Tensions Escalate and Oil Prices Surge
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Stocks Surge as Strait of Hormuz Reopens, Oil Prices Plunge
U.S. Dollar Steadies Near Multi-Week Lows Amid Iran Peace Talk Hopes and Global Market Shifts
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Asian Currencies Slip as Dollar Gains Safe-Haven Strength Amid U.S.-Iran Tensions
IMF Warns Middle East War to Deepen Economic Divide Across Latin America and Caribbean
Gold Prices Drop as Oil Rally and U.S.-Iran Tensions Shake Markets
The four types of dementia most people don’t know exist 



